Global Pharmaceuticals & Biotech Breakout Stocks

Sino BiologicalInc

Market Cap: CN¥17.0b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

Lin BioScience

Market Cap: NT$78.4b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

AcrobiosystemsLtd

Market Cap: CN¥16.0b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Eton Pharmaceuticals

Market Cap: US$1.7b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥11.1b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

Marksans Pharma

Market Cap: ₹150.2b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

Omeros

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥7.9b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

Boji Medical TechnologyLtd

Market Cap: CN¥6.7b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Climb Bio

Market Cap: US$937.9m

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥6.1b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥5.4b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Novoprotein Scientific

Market Cap: CN¥4.8b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

4D Molecular Therapeutics

Market Cap: US$673.4m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Oncolys BioPharma

Market Cap: JP¥102.2b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

Shanghai Kai Kai Industry

Market Cap: CN¥3.7b

Engages in the wholesale and retail of pharmaceutical products in China.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.6b

Operates as a pharmaceutical manufacturing holding investment company in China.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥2.6b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

Ind-Swift Laboratories

Market Cap: ₹27.2b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

Intelligene

Market Cap: NT$7.0b

Engages in the research and development of RNA gene therapy drugs in Taiwan and Australia.

Cardiol Therapeutics

Market Cap: CA$289.3m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Helix BioPharma

Market Cap: CA$142.8m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

Sareum Holdings

Market Cap: UK£38.8m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Apollomics

Market Cap: US$51.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Bilcare

Market Cap: ₹2.3b

Provides pharmaceutical packaging research solutions in India and internationally.

Aton

Market Cap: €14.1m

Operates as a bioscience company in France.

Pharmala Biotech Holdings

Market Cap: CA$20.2m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

OSR Health

Market Cap: US$11.1m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.

Brainstorm Cell Therapeutics

Market Cap: US$10.9m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Revive Therapeutics

Market Cap: CA$13.1m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Hepion Pharmaceuticals

Market Cap: US$6.7m

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.

Dannex Ayrton Starwin

Market Cap: GH₵68.7m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.

Enzolytics

Market Cap: US$2.9m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

International Stem Cell

Market Cap: US$2.8m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.